Giulia Veronesi, MD
Division of Thoracic Surgery, Humanitas Clinical and Research Center, Rozzano, Milan, Italy
Giulia Veronesi is Chief of the Robotic Surgery Unit at the Humanitas Hospital in Milan. Giulia Veronesi has received her Medical Degree at School of Medicine University of Milan, Italy. She completed her Residency in General Surgery at University of Milan and in Thoracic Surgery at the University of Modena. She was staff surgeon at the European Institute of Oncology from 2000 to 2015 where also headed the Lung Cancer Screening and Prevention Unit. In 2015 she was recruited to Humanitas Research Hospital as chief of the Robotic Unit in the Thoracic Surgery Division.
She has led one of the largest European lung cancer screening programs (COSMOS studies) using low dose tomography and MicroRNA testing in high risk individuals and was principal investigator of several lung cancer chemo prevention trials funded by the American National Cancer Institute including the randomized study on inhaled Budesonide compared to placebo for screen detected lung nodules the randomized study to evaluate the protective role of Aspirin in healthy subjects with subsolid lung lesions.
Since 2006 she has developed a robotic surgery program for oncological chest diseases, she is tutor in robotic surgery in Italy and other European countries.
She has designed and co-ordinated an international multicentre randomized trial to compare robotic and manual videotoroscopic surgery for the treatment of lung cancer and has instituted an European working group within the European Society of Thoracic Surgery (ESTS) on Robotics Surgery focused on training and education. She is founding member of the Clinical Robotic Surgical Association (CRSA) and member of the Prevention/early Detection Committee of the International Association on Study of Lung Cancer.
She is a member of several international editorial committees including Lung Cancer, eCancer, Frontiers in Oncology, Annals of Thoracic Surgery and various European and international scientific societies.
He has won a prize in 2017 of the Women and Technology Association as a techno-visionary in medicine. She has been invited speaker in over 110 national and international conferences and author of 170 scientific articles with a HI of 33 and IF 645.